Answers are grounded in this paper and cite their sources.
Case summary identifies biventricular thrombi in a patient with probable APS and cardiogenic shock, suggesting urgent evaluation and management.
BACKGROUND: Intracardiac thrombi are a rare manifestation of antiphospholipid syndrome (APS), with biventricular involvement being exceedingly uncommon. CASE SUMMARY: A 70-year-old woman with recent Takotsubo cardiomyopathy was admitted with cardiogenic shock. Imaging demonstrated large biventricular thrombi. Initial laboratory testing was consistent with probable APS. Inotropic support and anticoagulation were initiated. After failed attempts to wean inotropes, the patient elected hospice care. DISCUSSION: This case highlights the diagnostic uncertainty and limited evidence guiding management of extensive intracardiac thrombosis in patients with suspected APS presenting with cardiogenic shock. Beyond anticoagulation, the evidence base for managing intracardiac thrombi in probable APS is limited to case reports, and there are large risks associated with invasive strategies for removing intracardiac thrombi. TAKE-HOME MESSAGES: Rapid development of extensive multichamber intracardiac and systemic thrombosis should prompt evaluation for APS. Anticoagulation remains the cornerstone of therapy; evidence guiding invasive strategies is limited.
No takes yet. Share an insight, caveat, or question.
Contractor et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: